Table of Contents
Pharmacy technicians play a vital role in the management of patients receiving GLP-1 (glucagon-like peptide-1) pharmacotherapy. As the use of GLP-1 receptor agonists increases for conditions such as type 2 diabetes and obesity, it is essential that pharmacy technicians are well-educated about these therapies to support optimal patient care.
Overview of GLP-1 Pharmacotherapy
GLP-1 receptor agonists are a class of medications that mimic the action of the endogenous hormone GLP-1. They enhance insulin secretion, suppress glucagon release, slow gastric emptying, and promote satiety, leading to improved glycemic control and weight loss in many patients.
Learning Objectives
- Understand the mechanism of action of GLP-1 receptor agonists.
- Identify common medications within this class.
- Recognize potential side effects and contraindications.
- Learn proper counseling points for patients.
- Familiarize with storage, handling, and administration procedures.
Pharmacology and Mechanism of Action
GLP-1 receptor agonists work by activating GLP-1 receptors in the pancreas, stimulating insulin release when blood glucose levels are elevated. They also inhibit the release of glucagon, a hormone that raises blood glucose. Additionally, they slow gastric emptying and increase feelings of fullness, which can aid in weight management.
Common Medications
- Exenatide (Byetta, Bydureon)
- Liraglutide (Victoza, Saxenda)
- Dulaglutide (Trulicity)
- Semaglutide (Ozempic, Rybelsus, Wegovy)
- Albiglutide (Tanzeum) — discontinued but still relevant historically
Side Effects and Precautions
Common side effects include nausea, vomiting, diarrhea, and injection site reactions. Serious but rare risks involve pancreatitis and potential risk of thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2) should avoid these medications.
Counseling Points for Patients
- Instruct on proper injection technique and storage.
- Advise on possible gastrointestinal side effects and how to manage them.
- Emphasize the importance of adherence to dosing schedules.
- Inform about signs of serious side effects such as severe abdominal pain.
- Discuss the role of diet and lifestyle in conjunction with medication.
Handling and Administration
Most GLP-1 receptor agonists are administered via subcutaneous injection. Technicians should be familiar with reconstitution (if applicable), proper injection sites, and disposal of needles and syringes. Storage conditions vary; some medications require refrigeration while others are stable at room temperature for a limited time.
Conclusion
Educating pharmacy technicians about GLP-1 pharmacotherapy enhances their ability to support patients effectively. Staying current with medication updates, side effect management, and counseling techniques ensures optimal therapeutic outcomes and patient safety.